Development and validation of a sensitive HPLC-ESI-MS/MS method for the direct determination of glucosamine in human plasma
about
Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic propertiesQuantitation of glucosamine sulfate in plasma by HPLC-MS/MS after administration of powder for oral solution formulation.A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individualsPhysiological effects of oral glucosamine on joint health: current status and consensus on future research prioritiesDetermination of glucosamine and its derivatives released from photocrosslinked gelatin hydrogels using HPLC.Quantification of polar drugs in human plasma with liquid chromatography-tandem mass spectrometry.Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations.Liquid Chromatography with Electrospray Ionization and Tandem Mass Spectrometry Applied in the Quantitative Analysis of Chitin-Derived Glucosamine for a Rapid Estimation of Fungal Biomass in Soil.Pharmacokinetic Analysis of an Oral Multicomponent Joint Dietary Supplement (Phycox®) in Dogs.Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion.The Fate of Oral Glucosamine Traced by (13)C Labeling in the Dog.Precolumn derivatization LC-MS/MS method for the determination and pharmacokinetic study of glucosamine in human plasma and urine.Sensitive and rapid analytical method for the quantification of glucosamine in human plasma by ultra high performance liquid chromatography with tandem mass spectrometry.RECENT HPLC STRATEGIES TO IMPROVE SENSITIVITY AND SELECTIVITY FOR THE ANALYSIS OF COMPLEX MATRICESDetermination of Glucosamine in Human Plasma by High-Performance Liquid Chromatography-Atmospheric Pressure Chemical Ionization Source-Tandem Mass Spectrometry
P2860
Q21195259-7F098C12-A718-4F29-8ED6-167C444E53C7Q24630640-9EA8B81E-7ACA-4B95-A30E-9CFE5488D894Q34059484-469A60DA-EA7E-4C5A-AB53-FD8FC56109D5Q34588403-1EA6BBB0-E293-42EB-AC9D-634F11766716Q34636799-78D1BCF9-69EF-459B-8AFB-495C44B41A2EQ35656584-38958BAC-4ACF-4F45-BEEC-AF7DA09447E4Q37810210-37ABF4A6-EAC2-4F6C-AC5C-A7E7E05A02BCQ37960179-F820CC12-064C-46A7-88DF-E796CC3EEBE5Q38591683-51D9066F-031B-4D06-966A-50C15593D5C0Q38618573-A7E8749D-2663-4EF0-BC68-2A5FA373C014Q40666843-3197EE87-4412-481D-8942-D2B146A8A519Q41966032-E736A8CC-5984-4131-8167-495299034D66Q49742445-E31DB70D-BEEA-4FA7-8640-40429127083DQ53567904-6BDD20D9-EDEC-4574-806D-55CEF04BF0C7Q58493583-84C23D80-A2B0-4ADB-BCEC-118226A01A31Q58655402-DE3A548A-FE57-4735-958E-4E1CB225E0C8
P2860
Development and validation of a sensitive HPLC-ESI-MS/MS method for the direct determination of glucosamine in human plasma
description
article
@en
im August 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2006
@uk
name
Development and validation of ...... of glucosamine in human plasma
@en
Development and validation of ...... of glucosamine in human plasma
@nl
type
label
Development and validation of ...... of glucosamine in human plasma
@en
Development and validation of ...... of glucosamine in human plasma
@nl
prefLabel
Development and validation of ...... of glucosamine in human plasma
@en
Development and validation of ...... of glucosamine in human plasma
@nl
P2093
P50
P1476
Development and validation of ...... of glucosamine in human plasma
@en
P2093
Francesco Saverio Violante
Laura Sabatini
Massimo Guardigli
Stefano Persiani
P304
P356
10.1016/J.JCHROMB.2006.07.013
P407
P577
2006-08-22T00:00:00Z